Vanguard Global Advisers’s Sionna Therapeutics SION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30.7K Sell
5,831
-2,021
-26% -$46.4K ﹤0.01% 3231
2026
Q2
$345K Sell
7,852
-3,339
-30% -$134K ﹤0.01% 2268
2026
Q1
$449K Buy
+11,191
New +$427K ﹤0.01% 2095

Other funds holding SION

Vanguard Global Advisers's SION Position: Q3 2026 in Review

Vanguard Global Advisers reduced its Sionna Therapeutics (SION) stake by 26% in Q3 2026, selling an estimated $46.4K and leaving 5,831 shares worth $30.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3231.

Vanguard Global Advisers first reported a position in SION in Q1 2026 and has held it in 3 quarters since. The position peaked at $449K in Q1 2026. 136 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • Vanguard Global Advisers held 5,831 shares of Sionna Therapeutics worth $30.7K as of Q3 2026.
  • Vanguard Global Advisers sold 2,021 Sionna Therapeutics shares in Q3 2026, an estimated $46.4K.
  • Sionna Therapeutics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3231 holding.
  • Vanguard Global Advisers first reported a position in Sionna Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Sionna Therapeutics position peaked at $449K in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.